COVID

Advertisement
Feb 08 2025HEALTH

Overcoming Hurdles: A New Tool for Care Partners

The COVID-19 pandemic has been pretty tough on everyone. Now imagine how it has affected people with loved ones in long-term care (LTC), especially those living with dementia. When a loved one moves to LTC, caregivers suddenly have many responsibilities pulled away from them. This creates a new set

reading time less than a minute
Feb 07 2025HEALTH

Covid Vaccine Symptoms : What's the Deal?

Near the end of 2020 a wild idea sprung up to gather lots of volunteers to figure out certain long term problems that the new Covid vaccine could be causing. Soon the BiCoVac was ready to go. This was a big venture that took place across the whole of Denmark. This wasn't about how well

reading time less than a minute
Feb 07 2025HEALTH

The Vaccine Cash Quest: Does money convince more people to get vaccinated?

People are often motivated by cash, even for something as important as vaccinations. In the case of COVID-19 vaccines, previous studies have shown that financial bonuses raise the number of people who get the shot. These studies concluded that the direct impact of cash incentives could be small but

reading time less than a minute
Feb 07 2025HEALTH

What Happens to Kids' Guts After COVID-19?

In the long run, the impact of COVID-19 on the guts of children is a big mystery. Kids continue to have issues with their GI tracts. They are still having stomach problems even after they have recovered from the virus. This is a part of what doctors call the postacute and chronic phases. The out

reading time less than a minute
Feb 07 2025HEALTH

Long Covid: The Silent Struggle for Care in Brazil

Brazil is one place where you can see the Long Covid problem. Long Covid is a long-term condition that comes from Covid. Many people across the globe are suffering from it. It has many effects. COVID-19 can cause long-term health problems. It is hard to get the right care and treatment. Many pe

reading time less than a minute
Feb 07 2025HEALTH

Paxlovid: The Pill That Battles COVID-19

Paxlovid, a clever mix of nirmatrelvir and ritonavir, made headlines as it became the first approved oral treatment for those with mild-to-moderate COVID-19 symptoms. This combination is designed to tackle the virus with minimal fuss. Everything works quite well using two main actors in the body: t

reading time less than a minute
Feb 07 2025HEALTH

Working on the Frontlines: The Struggle of Substance Use Staff in Scotland

When you think about substance use services, you might not immediately consider the professionals working there. But these folks are fighting the good fight, and it's not great. We all know substance use is a huge problem, especially with rising death rates. We need a solid plan, and workers on the

reading time less than a minute
Feb 06 2025SCIENCE

“20 years of news Under The Lens: Spotlight on U. S. Risk ”

Over the past 20 years, news reports have given certain risky situations a special spotlight. This study looks at what makes some stories get more attention. To do this, researchers did something new. They used special tools, like topic modeling and time-series analysis. This involves analyzing a

reading time less than a minute
Feb 06 2025POLITICS

Realism over Ideals: The Path for Scientific Progress

In recent times, the federal government is expected to move towards a pragmatic approach in handling scientific matters. This shift aims to restore public confidence in government policies, which are rooted in science. The trust in government, especially science-based directives, has plummeted and h

reading time less than a minute
Feb 06 2025HEALTH

Tweets and Truths: How Experts and Others Spoke About COVID-19

During the COVID-19 pandemic, experts and others used Twitter to share crucial information with the public. The pandemic was a time of uncertainty. Communication became crucial. Public health experts (PHEs) needed to share information and engage with people. At the same time, others also us

reading time less than a minute